investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
Honami Naora
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Honami Naora
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Kim O'Neill
Cancer Immunology Research at Brigham Young University
Leukaemia
David FitzGerald
Bio-Therapies for the Treatment of Cancer
Leukaemia
Katherine L B Borden
Molecular Mechanisms of eIF4E mediated transformation
Leukaemia
Pathology
Hematology and hematologic malignancies
Gang Huang
Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes
Leukaemia
Catherine Ju-Ying Wu
Defining the impact of clonal evolution on chronic lymphocytic leukemia
Leukaemia
David Baltimore
MicroRNA Function in the Immune System
Leukaemia
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Hematology and hematologic malignancies
Soheil Meshinchi
Biology and Prognostic Implications of FLT3 Mutations in AML
Leukaemia
William E. Evans
Pharmacogenomics of Childhood Leukemia ALL
Leukaemia
Pediatric oncology or childhood cancer